Lauren Hill

455 total citations
31 papers, 329 citations indexed

About

Lauren Hill is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Lauren Hill has authored 31 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Ophthalmology, 29 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Molecular Biology. Recurrent topics in Lauren Hill's work include Retinal Imaging and Analysis (29 papers), Retinal Diseases and Treatments (29 papers) and Retinal and Optic Conditions (22 papers). Lauren Hill is often cited by papers focused on Retinal Imaging and Analysis (29 papers), Retinal Diseases and Treatments (29 papers) and Retinal and Optic Conditions (22 papers). Lauren Hill collaborates with scholars based in United States, Switzerland and Italy. Lauren Hill's co-authors include Ivaylo Stoilov, Shamika Gune, Anne E. Fung, David Eichenbaum, Daniel B. Roth, Charles C. Wykoff, Zdenka Hašková, David Sarraf, Rishi P. Singh and M. Cecilia Lansang and has published in prestigious journals such as Gastroenterology, Diabetes and Ophthalmology.

In The Last Decade

Lauren Hill

30 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lauren Hill United States 9 303 287 17 9 8 31 329
Kristin Josic United States 5 216 0.7× 194 0.7× 29 1.7× 7 0.8× 3 0.4× 6 238
Rita Serra Italy 9 212 0.7× 178 0.6× 23 1.4× 3 0.4× 32 261
Bernardete Pessoa Portugal 10 210 0.7× 148 0.5× 36 2.1× 1 0.1× 3 0.4× 33 230
Harinderjit Singh United States 8 259 0.9× 199 0.7× 21 1.2× 5 0.6× 16 297
Samara B. Marafon Canada 10 192 0.6× 215 0.7× 11 0.6× 20 2.2× 24 246
Michel Shami United States 5 523 1.7× 426 1.5× 43 2.5× 1 0.1× 11 1.4× 9 544
Verena R. Juncal Canada 11 325 1.1× 307 1.1× 27 1.6× 3 0.4× 35 369
Maja Gran Erke Norway 7 171 0.6× 146 0.5× 18 1.1× 4 0.5× 10 199
Bradley F. Jost United States 7 145 0.5× 104 0.4× 26 1.5× 4 0.4× 2 0.3× 15 162
Lloyd Clark United States 2 219 0.7× 202 0.7× 13 0.8× 2 0.3× 3 223

Countries citing papers authored by Lauren Hill

Since Specialization
Citations

This map shows the geographic impact of Lauren Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Hill more than expected).

Fields of papers citing papers by Lauren Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Hill. The network helps show where Lauren Hill may publish in the future.

Co-authorship network of co-authors of Lauren Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Hill. A scholar is included among the top collaborators of Lauren Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Hill. Lauren Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talcott, Katherine E., Carolina C. S. Valentim, Lauren Hill, Ivaylo Stoilov, & Rishi P. Singh. (2023). Baseline Diabetic Retinopathy Severity and Time to Diabetic Macular Edema Resolution with Ranibizumab Treatment. Ophthalmology Retina. 7(7). 605–611. 1 indexed citations
2.
Staurenghi, Giovanni, Mariano Cozzi, Srinivas R. Sadda, Lauren Hill, & Shamika Gune. (2022). Characteristics that Correlate with Macular Atrophy in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 7(4). 300–306. 9 indexed citations
3.
Freund, K. Bailey, Giovanni Staurenghi, Jesse J. Jung, et al.. (2022). Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(8). 2437–2447. 12 indexed citations
4.
Sadda, Srinivas R., Nancy M. Holekamp, David Sarraf, et al.. (2022). Relationship between retinal fluid characteristics and vision in neovascular age-related macular degeneration: HARBOR post hoc analysis. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(12). 3781–3789. 16 indexed citations
5.
Holekamp, Nancy M., Srinivas R. Sadda, David Sarraf, et al.. (2021). Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration. American Journal of Ophthalmology. 233. 8–17. 23 indexed citations
6.
Zarbin, Marco A., Lauren Hill, Andreas Maunz, Martin Gliem, & Ivaylo Stoilov. (2021). Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy. British Journal of Ophthalmology. 106(11). 1561–1566. 13 indexed citations
7.
Zarbin, Marco A., et al.. (2020). Anti-VEGF Resistant Subretinal Fluid is Associated With Reduced Risk of Macular Atrophy and Better Visual Acuity: Drug-Induced Choroidal New Vessel Homeostasis?. Investigative Ophthalmology & Visual Science. 61(7). 3503–3503. 2 indexed citations
8.
Khurana, Rahul N., et al.. (2020). Agreement of Spectral-Domain OCT with Fluorescein Leakage in Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 4(11). 1054–1058. 5 indexed citations
9.
Dhoot, Dilsher S., et al.. (2020). Baseline Factors Associated with Diabetic Retinopathy Improvement in RIDE/RISE. Ophthalmology Retina. 5(1). 101–103.
10.
Chiang, Allen, Sunir J. Garg, Michael A. Klufas, et al.. (2020). Ultra-Response to Ranibizumab: Improvement by 4 or More Steps in Diabetic Retinopathy Severity in Diabetic Retinopathy Clinical Research Network Protocol S. Ophthalmology Retina. 5(3). 251–260. 3 indexed citations
11.
Sadda, Srinivas R., et al.. (2019). Relationship between sub retinal fluid (SRF) and vision outcomes in eyes with neovascular age-related macular degeneration (nAMD) in the HARBOR trial. Investigative Ophthalmology & Visual Science. 60(9). 5189–5189. 2 indexed citations
12.
Khurana, Rahul N., et al.. (2019). The Value of Prior Response to Anti–Vascular Endothelial Growth Factor for Age-Related Macular Degeneration. Ophthalmology Retina. 4(1). 13–18. 1 indexed citations
13.
Miller, Daniel M., et al.. (2019). Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration?. Ophthalmology Retina. 4(2). 141–147. 8 indexed citations
14.
Zarbin, Marco A., et al.. (2019). Simulating an Anti–Vascular Endothelial Growth Factor Switch in Neovascular Age-Related Macular Degeneration. Ophthalmology. 126(6). 849–855. 8 indexed citations
15.
Dhoot, Dilsher S., et al.. (2018). Baseline factors associated with ≥ 2-step diabetic retinopathy (DR) severity improvement with ranibizumab (RBZ). Investigative Ophthalmology & Visual Science. 59(9). 3592–3592. 1 indexed citations
16.
Wykoff, Charles C., David Eichenbaum, Daniel B. Roth, et al.. (2018). Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy. Ophthalmology Retina. 2(10). 997–1009. 69 indexed citations
17.
Wykoff, Charles C., et al.. (2016). Ranibizumab induces regression of diabetic retinopathy (DR) in more than three-quarters of patients with high-risk non-proliferative diabetic retinopathy (NPDR) independent of retinal nonperfusion. Investigative Ophthalmology & Visual Science. 57(12). 1 indexed citations
18.
Singh, Rishi P., et al.. (2016). The Impact of Systemic Factors on Clinical Response to Ranibizumab for Diabetic Macular Edema. Ophthalmology. 123(7). 1581–1587. 57 indexed citations
19.
Sarraf, David, Nikolas London, Rahul N. Khurana, et al.. (2016). Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration. Ophthalmology. 123(10). 2213–2224. 47 indexed citations
20.
Khanani, Arshad M., Lauren Hill, & Lisa Tuomi. (2015). Improvement in visual acuity following ranibizumab treatment in neovascular age-related macular degeneration patients with large pigment epithelial detachments: a subgroup analysis of the HARBOR study. Investigative Ophthalmology & Visual Science. 56(7). 5363–5363. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026